Chlo Hist Liquid
Product Images NDC 12830-864

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Chlo Hist (NDC 12830-864). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by R. A. Mcneil Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chlo Hist Labeling 1 (Chlo Hist Labeling 1)

Chlo Hist Labeling 1 (Chlo Hist Labeling 1)
This is a description for Chlo Hist Oral Solution, manufactured by RA. MoNell Company. The solution is designed to provide temporary relief from coughing, runny nose, sneezing, and throat irritation. It contains a non-narcotic cough suppressant and antihistamine. The solution should be kept in a tightly sealed, light-resistant container with a child-resistant cap. The bottle has a tamper-evident foil seal under the cap, which should not be used if broken or missing. It is cautioned to avoid alcoholic beverages while taking this product, as it may cause drowsiness. It should be used carefully when driving or operating machinery. Prior consultation with a doctor is recommended if there is a cough that lasts for a long time, breathing problems, or glaucoma. The solution should not be dispensed to the consumer. The US Patent number 9,050,289 is mentioned. Rev. 09/17 is also stamped on the bottle.*
FDA Label Image

Chlo Hist Labeling 2 (Chlo Hist Labeling 2)

Chlo Hist Labeling 2 (Chlo Hist Labeling 2)
This is a set of instructions and warnings for correctly using a product aimed at alleviating cough or nasal congestion. It warns about the risks of drowsiness or increased drowsiness with certain activities and substances, including alcohol and sedatives, and indicates the maximum doses that must not be exceeded. The product should be discontinued and medical assistance sought in case of new or persistent symptoms or overdose. It also contains a list of inactive ingredients and a phone number to report serious side effects.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.